FERLAZZO, Guido
 Distribuzione geografica
Continente #
EU - Europa 8.300
NA - Nord America 8.111
AS - Asia 3.996
SA - Sud America 1.294
Continente sconosciuto - Info sul continente non disponibili 322
AF - Africa 112
OC - Oceania 7
Totale 22.142
Nazione #
US - Stati Uniti d'America 7.868
RU - Federazione Russa 4.186
SG - Singapore 1.618
CN - Cina 1.248
BR - Brasile 1.124
IE - Irlanda 854
IT - Italia 788
SE - Svezia 764
HK - Hong Kong 436
DE - Germania 320
UA - Ucraina 300
PL - Polonia 265
FR - Francia 244
VN - Vietnam 223
GB - Regno Unito 166
FI - Finlandia 153
IN - India 108
CA - Canada 106
AR - Argentina 60
MX - Messico 55
BD - Bangladesh 51
BE - Belgio 46
TR - Turchia 42
AT - Austria 41
ZA - Sudafrica 41
CZ - Repubblica Ceca 34
NL - Olanda 34
JP - Giappone 32
ID - Indonesia 31
IQ - Iraq 31
EC - Ecuador 27
ES - Italia 27
MA - Marocco 21
CO - Colombia 20
PK - Pakistan 19
UZ - Uzbekistan 19
CR - Costa Rica 17
JM - Giamaica 17
SA - Arabia Saudita 17
PY - Paraguay 16
VE - Venezuela 16
CL - Cile 12
KR - Corea 12
TN - Tunisia 12
MY - Malesia 11
PH - Filippine 11
AE - Emirati Arabi Uniti 10
LT - Lituania 10
IR - Iran 9
KZ - Kazakistan 9
NP - Nepal 9
AZ - Azerbaigian 8
HN - Honduras 8
KE - Kenya 8
SV - El Salvador 8
AL - Albania 7
BO - Bolivia 7
EE - Estonia 7
EG - Egitto 7
IL - Israele 7
GT - Guatemala 6
NI - Nicaragua 6
RO - Romania 6
RS - Serbia 6
UY - Uruguay 6
DO - Repubblica Dominicana 5
GR - Grecia 5
PE - Perù 5
AU - Australia 4
BY - Bielorussia 4
DZ - Algeria 4
ET - Etiopia 4
JO - Giordania 4
LU - Lussemburgo 4
LV - Lettonia 4
OM - Oman 4
PA - Panama 4
PR - Porto Rico 4
TH - Thailandia 4
AM - Armenia 3
CH - Svizzera 3
CI - Costa d'Avorio 3
DK - Danimarca 3
HU - Ungheria 3
KH - Cambogia 3
LB - Libano 3
NZ - Nuova Zelanda 3
SI - Slovenia 3
TT - Trinidad e Tobago 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BA - Bosnia-Erzegovina 2
EU - Europa 2
GA - Gabon 2
LA - Repubblica Popolare Democratica del Laos 2
MD - Moldavia 2
MK - Macedonia 2
PS - Palestinian Territory 2
PT - Portogallo 2
SC - Seychelles 2
SK - Slovacchia (Repubblica Slovacca) 2
Totale 21.798
Città #
Ashburn 1.358
Moscow 1.178
Singapore 922
Dublin 858
Chandler 684
Dallas 673
Jacksonville 551
San Jose 519
Nyköping 500
Hong Kong 435
Beijing 413
Messina 342
Council Bluffs 262
Warsaw 253
The Dalles 229
Los Angeles 184
Princeton 150
Ann Arbor 147
Lauterbourg 138
Medford 138
Cambridge 117
Des Moines 110
Boardman 107
New York 104
São Paulo 83
Buffalo 82
Munich 71
Santa Clara 68
Dearborn 66
Jinan 64
Ho Chi Minh City 61
Tianjin 54
Guangzhou 49
Hanoi 47
Frankfurt am Main 44
Redondo Beach 44
Brussels 43
Shenyang 42
Rome 40
Woodbridge 40
Phoenix 38
Rio de Janeiro 38
Wilmington 36
Belo Horizonte 35
Seattle 35
Vienna 33
Chicago 32
Brno 31
Milan 31
Orem 29
Tokyo 29
Brooklyn 28
Nanjing 28
Stockholm 27
Chennai 26
Hebei 26
Johannesburg 26
Catania 25
Houston 25
Zhengzhou 25
Atlanta 24
Montreal 24
San Mateo 24
Shanghai 24
Brasília 22
Haikou 22
Lancaster 22
Changsha 20
Dong Ket 20
London 20
Taizhou 20
Turku 20
Amsterdam 19
Tashkent 19
Denver 18
San Francisco 18
Ningbo 17
Sorocaba 17
Toronto 17
Curitiba 16
Düsseldorf 16
Jakarta 16
Hyderabad 15
Nanchang 15
Saint Petersburg 15
Boston 14
Campinas 14
Hangzhou 14
Helsinki 14
Nuremberg 14
Porto Alegre 14
Pune 14
Shenzhen 14
Ribeirão Preto 13
San José 13
Columbus 12
Mumbai 12
Naples 12
Caxias do Sul 11
Fuzhou 11
Totale 12.549
Nome #
HLA-C*17 in COVID-19 patients: hints for associations with severe clinical outcome and cardiovascular risk 270
A multivariate analysis of Multiple Myeloma subtype plasma cells 259
Symptomatic carotid atherosclerotic plaques are associated with increased infiltration of natural killer (NK) cells and higher serum levels of NK activating receptor ligands 256
NCR(+)ILC3 concentrate in human lung cancer and associate with intratumoral lymphoid structures. 233
Divergent signaling pathways regulate IL-12 production induced by different species of Lactobacilli in human dendritic cells 221
Membrane transfer from tumor cells overcomes deficient phagocytic ability of plasmacytoid dendritic cells for the acquisition and presentation of tumor antigens. 216
Acquisition and presentation of tumor antigens by dendritic cells. 209
Curcumin ameliorates the in vitro efficacy of carfilzomib in human multiple myeloma U266 cells targeting p53 and NF-kB pathways 207
CD56(bright) CD16(-) killer Ig-like receptor(-) NK cells display longer telomeres and acquire features of CD56(dim) NK cells upon activation 206
Oxidative stress induces Wnt canonical/non-canonical pathways modulation in colon cancer cell models 203
Seroma fluid subsequent to axillary lymph node dissection for breast cancer derives from an accumulation of afferent lymph. 202
A mixture of bacterial mechanical lysates is more efficient than single strain lysate and of bacterial-derived soluble products for the induction of an activating phenotype in human dendritic cells. 202
An historical overview: The discovery of how NK cells can kill enemies, recruit defense troops, and more 199
Changes in plasma 5-HT levels and equine leukocyte SERT expression in response to treadmill exercise 199
Biological parameters in breast cancer 197
Cerebral venous sinus thrombosis (CVST) associated with SARS-CoV-2 vaccines: clues for an immunopathogenesis common to CVST observed in COVID-19 194
Characterization and functional analysis of the human microRNA 363 in glioblastoma transfected cell lines 191
Mechanical bacterial lysate enhances antimicrobial barrier mechanisms in human airway epithelial cells 190
Intralesional sonographically guided injections of lymphokine- activated killer cells and recombinant interleukin-2 for the treatment of liver tumors: A pilot study 190
Arginase 2 is expressed by human lung cancer, but it neither induces immune suppression, nor affects disease progression 189
A PHASE-I STUDY OF INTRAVESICAL CONTINUOUS PERFUSION OF RECOMBINANT INTERLEUKIN-2 IN PATIENTS WITH SUPERFICIAL BLADDER- CANCER 188
Cross-dressing: an alternative mechanism for antigen presentation 188
Natural killer cells in the innate immunity network of atherosclerosis. 188
CD56(bright)perforin(low) noncytotoxic human NK cells are abundant in both healthy and neoplastic solid tissues and recirculate to secondary lymphoid organs via afferent lymph. 187
A think tank of TINK/TANKs: tumor-infiltrating/tumor-associated natural killer cells in tumor progression and angiogenesis 185
CLASS-I HLA AND ICAM-1 MOLECULE EXPRESSION IN PRIMARY CULTURED CANCER-CELLS DECREASES IN A STATIONARY-PHASE OF CELL-GROWTH 184
MiRNA expression profiling in human gliomas: upregulated miR-363 increases cell survival and proliferation 184
Detection Of Lynphocytic β - Endorphin In Cancer Patients During Hospedalization And After In Vitro Culture With IL 2. 184
A non-canonical adenosinergic pathway led by CD38 in human melanoma cells induces suppression of T cell proliferation 183
Human hepatitis B virus negatively impacts the protective immune cross-talk between natural killer and dendritic cells 182
METALLIC MICROSPHERE CONJUGATED MONOCLONAL-ANTIBODIES SPECIFIC FOR A CELL-SURFACE DETERMINANT ENHANCE DAMAGE TO CANCER-CELLS EXPOSED TO SHOCK-WAVES 180
Biological parameters in breast cancer. 180
Susceptibility of Human Melanoma Cells to Autologous Natural Killer (NK) Cell Killing: HLA-Related Effector Mechanisms and Role of Unlicensed NK Cells 179
Dendritic cell recognition by ILC3 via DNAM-1 triggers pro-inflammatory reciprocal cell activations 178
SPONTANEOUS TRANSFORMATION AND IMMORTALIZATION OF PERITONEAL- MACROPHAGES OF HUMAN-ORIGIN 176
FCM detection of lymphocytic beta-endorphin in cancer patients during hospitalization and after in vitro culture with IL2 174
Human NK cells of mice with reconstituted human immune system components require pre-activation to acquire functional competence. 174
Myeloma cells induce the accumulation of activated CD94low NK cells by cell-to-cell contacts involving CD56 molecules 173
Potential effects of vaccinations on the prevention of COVID-19: rationale, clinical evidence, risks, and public health considerations 173
Intralesional sonographically guided injections of lymphokine-activated killer cells and recombinant interleukin-2 for the treatment of liver tumors: a pilot study. 172
ILC in chronic inflammation, cancer and targeting with biologicals 172
Circulating ILC precursors expressing CD62L exhibit a type 2 signature distinctly decreased in psoriatic patients 172
Association Between Response to Nivolumab Treatment and Peripheral Blood Lymphocyte Subsets in Patients With Non-small Cell Lung Cancer 171
Cutting Edge: Hyperinflammatory Monocytes Expressing CD56 Abound in Severe COVID-19 Patients 170
Attenuated immune control of Epstein–Barr virus in humanized mice is associated with the multiple sclerosis risk factor HLA-DR15 169
T cell polarizing properties of probiotic bacteria 167
Cytotoxic effects of high energy shock waves on cancer cells linked to metallic beads vehicled by monoclonal antibodies 166
Role of natural killer cells in the pathogenesis and progression of multiple sclerosis 165
CTLA-4 is expressed by human monocyte-derived dendritic cells and regulates their functions. 165
Monocyte to HDL ratio: a novel marker of resistant hypertension in CKD patients 161
In vitro VLA-4 blockade results in an impaired NK cell-mediated immune surveillance against melanoma 161
Correlation between Hyperkalemia and the Duration of Several Hospitalizations in Patients with Chronic Kidney Disease 160
Crosstalk between ILC3s and Microbiota: Implications for Colon Cancer Development and Treatment with Immune Check Point Inhibitors 160
Neutrophil-like Monocytes Increase in Patients with Colon Cancer and Induce Dysfunctional TIGIT+ NK Cells 157
Adherent neoplastic cells grown at confluence downregulate HLA class I expression and enhance their susceptibility to lysis mediated by natural killer cells 157
Oxidative Stress Induces WNT Canonical/Non-Canonical Pathway Modulation in Colon Cancer Cells with APC or beta-Catenin Mutation 157
The Yin and Yang of Innate Lymphoid Cells in Cancer 156
Evaluation of the canonical/non-canonical Wnt signalling pathways during oxidative stress in colorectal cancer cell line models 155
FITC-labelled clone from phage display for direct detection of leukemia cells in blood 155
The anti-tumor activity of bacillus Calmette-Guerin in bladder cancer is associated with an increase in the circulating level of interleukin-2 154
Adaptative immunotherapy of advanced solid tumors 154
Curcumin potentiates the antitumor activity of Paclitaxel in rat glioma C6 cells 153
Human NK cells and NK receptors. 153
Phytochemicals, Antioxidant and Antiproliferative Properties of Rosmarinus officinalis L on U937 and CaCo-2 Cells 153
Potential predictive role of gut microbiota to immunotherapy in HCC patients: a brief review 151
Adoptive immunotherapy of advanced solid tumors: An eight year clinical experience 150
The Immune Inhibitory Receptor LAIR-1 Is Highly Expressed by Plasmacytoid Dendritic Cells and Acts Complementary with NKp44 to Control IFN-α Production 150
Detection of MAGE-1, -2 and -3 messenger RNA in tissue samples derived from lung and mammary tumors. 149
Characterization of human afferent lymph dendritic cells from seroma fluids. 148
Analysis of HLA-class-I specific natural killer cell receptors expressed on T lymphocytes infiltrating non-small-cell lung cancer 147
Role of natural killer and dendritic cell crosstalk in immunomodulation by commensal bacteria probiotics. 144
In vitro modulation of lymphocytes ß-endorphin (ß-END) studied by flow cytometry. 144
Effect of oxidative stress on canonical/non-canonical WNT pathways in colon cancer cell lines 143
Multiple Myeloma Cells Shift the Fate of Cytolytic ILC2s Towards TIGIT-Mediated Cell Death 142
Anti-SARS-CoV2 IgG are present in the amniotic fluid of both infected and vaccinated women at second trimester of pregnancy: a cohort study 142
Mucosal Immunology and Probiotics. 142
EMODERIVATO IN FORMA DI GEL COMPRENDENTE FIBRINA, PIASTRINE E LEUCOCITI 142
Vitamin D and inflammatory bowel disease 141
Flavonoid profile, antioxidant and cytotoxic activity of different extracts from Algerian Rhamnus alaternus L. bark 140
Interleukins 12 and 15 induce cytotoxicity and early NK-cell differentiation in type 3 innate lymphoid cells 139
null 135
EPS T14 from Bacillus licheniformis Prevents Infection of Human Nasal Epithelial Cells by Respiratory Viruses 133
BNT162b2 COVID-19 vaccination elicits the expansion of CD16+CD8+ T cells endowed with natural killer cell features 133
Th17 skewing in the GALT of a Crohn disease patient upon Lactobacillus rhamnosus GG consumption 133
Raman spectroscopy is able to discriminate between CD138-/CD138+ plasmacells of multiple myeloma patients. 133
Influence of Vitamin D in Advanced Non-Small Cell Lung Cancer Patients Treated with Nivolumab 133
CD62L expression identifies a unique subset of polyfunctional CD56dim NK cells. 132
Cognate HLA absence in trans diminishes human NK cell education 130
Drag cells in immunity: Plasmacytoid DCs dress up as cancer cells. 128
On immunostimulants and dendritic cell activation 128
Phage-phenotype imaging of myeloma plasma cells by phage display 128
MORPHOLOGICAL, PHENOTYPIC AND KARYOTYPIC CHARACTERIZATION OF A NOVEL NATURAL-KILLER-CELL TARGET - EVIDENCE OF INVOLVEMENT OF MHC CLASS-I MOLECULES IN NK CELL RECOGNITION 127
Molecular mechanisms directing migration and retention of natural killer cells in human tissues 126
NK cells provide helper signal for CD8+ T cells by inducing the expression of membrane-bound IL-15 on DCs 125
Expansion of natural killer cells in patients with head and neck cancer: Detection of "noninhibitory" (activating) killer Ig-like receptors on circulating natural killer cells 125
Chitosan/hyaluronan nanoparticles: a promising tool in cancer immunotherapy 121
T lymphocytes express B7 family molecules following interaction with dendritic cells and acquire bystander costimulatory properties 117
Identification of Natural Killer Cells in Tissues and Their Isolation 117
Natural Killers Are Made Not Born: How to Exploit NK Cells in Lung Malignancies 117
Microbiota and plasticity of antigen-presenting ILC3s: impact on antitumor immune response 117
Totale 16.560
Categoria #
all - tutte 75.365
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 75.365


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022752 0 0 0 31 46 16 74 52 14 64 130 325
2022/20232.633 232 261 119 217 195 260 37 163 1.030 10 63 46
2023/2024664 63 106 82 39 55 117 22 28 8 31 5 108
2024/20253.252 66 40 58 196 155 118 74 754 771 216 280 524
2025/20269.997 506 619 669 692 866 2.067 1.198 1.315 1.255 445 178 187
2026/20271.606 163 352 505 586 0 0 0 0 0 0 0 0
Totale 22.142